Dear Colleague:
We would like to invite you to the Pharmaceutical Strategy Series’ Fourth Annual executive forum “Post-Approval Drug Safety Strategies: Best Practices to Assess and Mitigate Risks throughout the Product’s Life Cycle” being held November 4-6, 2009 at The Crowne Plaza-Philadelphia Center in Philadelphia, PA.
Improving products’ clinical safety will increase the industry’s fundamental value proposition to patients, healthcare providers, payors and regulators. The program will focus on pharmacovigilance program implementation and specific strategies and approaches to creating true value from a peri- and post-approval drug safety program. The approach of this conference is not to look at safety in the silos of early-phase safety or post-approval safety but to view safety holistically, across the lifecycle, especially at the transition from approval to broader use in the marketplace.
The special, three-day executive forum entitled will tackle many of the pressing issues that executives are facing today, will have attendee-driven sessions in the form of breakout discussion groups, and will feature two half-day, case study-based workshops on “Developing and Implementing a Risk Management Plan” and“Practical Approaches to Lifecycle Signal Detection.”
The Pharmaceutical Strategy Series’ (PSS) mission is to assist in improving the overall health of the pharmaceutical industry by producing high-level meetings that bring together R&D leaders to discuss and debate potential solutions to overcoming the most pressing challenges facing their organizations.
I hope you can join us on November 4-6, 2009 in Philadelphia, PA to discuss and debate this emerging drug safety paradigm and how innovative drug safety risk assessment, management and mitigation hold the promise of creating considerable value for the industry.
Very sincerely,
Micah Lieberman
For questions or suggestions about the meeting, please contact:
Micah Lieberman
Executive Director, Conferences
Pharmaceutical Strategy Series
Cambridge Healthtech Institute (CHI)
T: (+1) 541.482.4709
E: mlieberman@pharmaseries.com
For exhibit, partnering and sponsorship information, please contact:
Arnold Wolfson
Business Development Manager
Pharmaceutical Strategy Series
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5431
E: awolfson@healthtech.com
For media and association partnerships, please contact:
Alec Frazier
Manager, Marketing
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5459
E: afrazier@healthtech.com